| TG THERAPEUTICS DL -,001 |
| USA |
| Gesundheit |
| US88322Q1085 / A1JXW7 |
| NKB2 (Frankfurt) / TGTX (NASDAQ) |
| FRA:NKB2, ETR:NKB2, NKB2:GR, NASDAQ:TGTX |
| - |
| http://www.tgtherapeutics.. |
|
TG Therapeutics, Inc. is a biopharmaceutical compa..
>Volltext.. |
| 4327.27 Mio. EUR |
| 4431.32 Mio. EUR |
| 453.06 Mio. EUR |
| 87.75 Mio. EUR |
| 381.15 Mio. EUR |
| 2.62 EUR |
| 216.11 Mio. EUR |
| 63.1 Mio. EUR |
| -59.69 Mio. EUR |
| 0.84 |
| 90.6% |
| - |
| - |
| - |
| - |
| TG THERAPEUTICS, TG THERAPEUTIC, TG THERA |
| 17.12.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|